Investment

Company alerts ❯

• March 20, 2023
  Histogen

  Histogen (NAS: HSTO)

  Also known as: #N/A

  LT 2203

  203 of 520

  Histogen is a clinical-stage therapeutics company focused on developing potential first-in-class restorative therapeutics that ignite the body’s natural process to repair and maintain healthy biological function. Histogen’s innovative technology platform utilizes cell conditioned media and extracellular matrix materials produced by hypoxia-induced multipotent cells. Histogen’s proprietary, reproducible manufacturing process provides targeted solutions across a broad range of therapeutic indications including hair growth, dermal rejuvenation, joint cartilage regeneration and spinal disk repair.

  Longevity pillar

  • Renewal
  • Treatment

  Longevity domain:

  • Regeneration
  • Advanced Aesthetics

  Location: United States

  Year founded: 01-Jan-07

  Longevity target: Aging Disease

  Proprietary analysis by Longevity.Technology, according to Pitchbook Data data as of March 21, 2023

  announces US patent covering CTS-2090 for inflammatory diseases. Read more
• March 17, 2023
  The

  Oura

  Oura Health

  Also known as: Ōura

  LT 2339

  339 of 520

  Oura Health is the developer of a wellness wearable ring designed to track and improve the quality of sleep and performance. The company's product tracks sleep quality, stages, ECG level resting heart rate and variability as well as body temperature during the night through an intelligent data-driven plan by detecting changes in blood pulse volume, enabling users to improve their sleep, overall health, and align to their natural circadian rhythm.

  Longevity pillar

  • Prevention

  Longevity domain:

  • Longevity lifestyle

  Location: Finland

  Year founded: 01-Jan-13

  Longevity target: Longevity determinant

  Proprietary analysis by Longevity.Technology, according to Pitchbook Data data as of March 21, 2023

  ring just got new sleep features that even the Apple Watch doesn’t have. Read more
• March 17, 2023
  TruDiagnostic

  TruDiagnostic

  Also known as: #N/A

  LT 2441

  441 of 520

  Founded in 2020, TruDiagnostic has already been making headway in the longevity industry with a mission to improve people's lives. TruDiagnostic wants to arm patients and physicians with information, enabling them to make the right decisions at the right times through insights found in the fluid epigenome

  Longevity pillar

  • Diagnostic
  • Prevention

  Longevity domain:

  • Longevity diagnostics

  Location: United States

  Year founded: 01-Jan-20

  Longevity target: Aging Driver

  Proprietary analysis by Longevity.Technology, according to Pitchbook Data data as of March 21, 2023

  and NADMED launch new blood diagnostic in US. Read more
• March 16, 2023
  BlueRock Therapeutics

  BlueRock Therapeutics

  Also known as: BlueRock

  LT 2075

  75 of 520

  BlueRock is a developer of a new generation of authentic and engineered cell therapies created to impact various diseases. The company develops induced pluripotent stem cell therapies to cure a range of diseases with the help of regenerative medicines across neurology, cardiology and immunology indications, thus enabling healthcare professionals to deliver advanced care and ensure fast recovery of the patients suffering from intractable diseases. BlueRock has a superior understanding and know-how of the intricate requirements needed to differentiate pluripotent cells into specific cells in the body – neuronal cells, cardiac cells, immune cells and more.

  Longevity pillar

  • Renewal
  • Treatment

  Longevity domain:

  • Regeneration
  • Longevity Genetics

  Location: United States

  Year founded: 01-Jan-16

  Longevity target: Aging Disease, Aging Driver

  Proprietary analysis by Longevity.Technology, according to Pitchbook Data data as of March 21, 2023

  to use Rune Labs' clinical trial platform to better characterize Parkinson's disease state in cell therapy trials. Read more
• March 16, 2023
  Celmatix

  Celmatix

  Also known as: #N/A

  LT 2097

  97 of 520

  Celmatix is a preclinical-stage biotech transforming women’s lives through better ovarian health.

  Longevity pillar

  • Treatment

  Longevity domain:

  • Discovery platforms
  • Reproductive longevity

  Location: United States

  Year founded: 01-Jan-09

  Longevity target: Aging Driver, Aging Disease

  Proprietary analysis by Longevity.Technology, according to Pitchbook Data data as of March 21, 2023

  and global collaborators release findings from largest genetic study to date on endometriosis. Read more
• March 16, 2023
  Cambrian

  Cambrian Biopharma

  Also known as: #N/A

  LT 2084

  84 of 520

  Cambrian Biopharma is building the medicines that will redefine healthcare in the 21st century – therapeutics to lengthen healthspan, the period of life spent in good health. Over the next 10 or 15 years, Cambrian wants to bring the way that we treat the diseases of aging into the 21st century by preventing them from happening, instead of waiting for people to get sick

  Longevity pillar

  • Prevention

  Longevity domain:

  • Longevity platforms
  • Longevity drugs

  Location: United States

  Year founded: 01-Jan-19

  Longevity target: Aging Driver

  Proprietary analysis by Longevity.Technology, according to Pitchbook Data data as of March 21, 2023

  Bio reveals new pipeline company with focus on AMPK activation. Read more